Elanco Animal Health (ELAN) Net Cash Flow Growth (3y) (2020 - 2026)
Elanco Animal Health (ELAN) Net Cash Flow Growth (3y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.33 Bn | 87.46 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.86 Bn | 32.12 Bn | 1.97 Bn | 32.03% |
| 3 | Zoetis | 32.54 Bn | 30.60 Bn | 1.62 Bn | 28.99% |
| 4 | Takeda Pharmaceutical | 27.63 Bn | 23.57 Bn | 4.39 Bn | 37.89% |
| 5 | United Therapeutics | 23.12 Bn | 20.96 Bn | 648.10 Mn | -49.94% |
| 6 | RedHill Biopharma | 21.80 Bn | 21.80 Bn | - | - |
| 7 | Viatris | 20.26 Bn | 18.46 Bn | 1.16 Bn | 37.74% |
| 8 | Neurocrine Biosciences | 17.79 Bn | 16.47 Bn | 800.70 Mn | -41.05% |
| 9 | Elanco Animal Health | 12.65 Bn | 12.22 Bn | 785.00 Mn | -62.71% |
| 10 | Vireo Growth | 10.52 Bn | 10.37 Bn | 59.30 Mn | 73.08% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -62.71% |
| Dec 31, 2025 | 29.60% |
| Sep 30, 2025 | -27.22% |
| Jun 30, 2025 | -48.12% |
| Mar 31, 2025 | 67.49% |
| Dec 31, 2024 | -34.19% |
| Sep 30, 2024 | 36.54% |
| Jun 30, 2024 | 9.09% |
| Mar 31, 2024 | -29.33% |
| Dec 31, 2023 | 54.87% |
| Sep 30, 2023 | 26.13% |
| Jun 30, 2023 | -31.58% |
| Mar 31, 2023 | -26.61% |
| Dec 31, 2022 | -73.75% |
| Sep 30, 2022 | 43.08% |
| Jun 30, 2022 | 24.26% |
| Mar 31, 2022 | 7.05% |
| Dec 31, 2021 | 39.46% |
| Sep 30, 2021 | -30.14% |
| Jun 30, 2021 | -5.06% |